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CONTRACTS AND REGISTRATION STUDIES 
DONALD J. ELIAS, RAY T. SI'ERNER, and PETER J. SAV ARIE, U.S. Department of Agriculture, Animal and 
Plant Health Inspection Service, Animal Damage Control, Denver Wildlife Research Center, Denver, Colorado 80225-
0266. 
ABSTRACT: Public and governmental concerns about the health, safety, and environmental impacts of pesticides have 
led to increased regulatory requirements to determine the hazards and risks associated with their manufacture, 
distribution, and use. Vertebrate pesticides are regulated by the U.S. Environmental Protection Agency (EPA) under 
the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA), as amended. Much of the data required for 
registration of these pesticides will be generated by commercial testing laboratories under contract to the product 
registrants or sponsors. In this paper, we address aspects of the contract research process including: 1) an overview 
of FIFRA requirements, 2) the nature of the contract research process, 3) guidelines for setting up and administering 
a contract for this type of work, and 4) several case studies to illustrate some of the •pitfalls• that may be encountered. 
The information presented is based on the collective experience of the authors' involvement with 49 contracted studies 
over a three-year period. 
INTRODUCTION 
The registration or reregistration of vertebrate 
pesticides entails the generation of chemical and biological 
data to satisfy Environmental Protection Agency (EPA) 
requirements under the Federal Fungicide, Insecticide, 
and Rodenticide Act (FIFRA), as amended. The law 
requires EPA to weigh the benefits derived from the use 
of a pesticide against any potential risks to public health 
and the environment. FIFRA requires that pesticides be 
registered by EPA and authorizes the Agency to require 
submission of data to facilitate the benefit-risk assessments 
(Conner et al. 1991). EPA data requirements are set 
forth in the U.S. Code of Federal Regulations at 40 
C.F.R. part 158 (Giles 1991) and are divided into 12 
categories which are designed to identify the composition 
of the pesticide and to reflect the effects of the pesticide 
on humans, non-target wildlife, and the environment. 
The test data are intended to demonstrate that the product 
will perform its intended function without unreasonable 
adverse effects as defined within the FIFRA § 3(c)(S) or 
3(c)(7). Several of the more significant categories of data 
requirements affecting vertebrate pesticides and the 
reasons for the requirements are the following . Product 
Chemistry data provide a profile of the physical and 
chemical characteristics of the product and associated 
impurities. Toxicology studies are intended to show the 
toxicological properties of the pesticide based on the route 
of exposure (oral, dermal , inhalation, ocular), the 
duration of exposure (acute, subchronic, chronic), and the 
types of effects (neurotoxicity, teratology, oncogenicity, 
reproduction, mutagenicity, etc.). Wildlife and Aquatic 
tests are aimed primarily at determining toxicity to non-
target species of birds, mammals, fish, or aquatic 
invertebrates. Residue Chemistry data are required for 
pesticides used on a food or feed crop and are used to set 
and enforce pesticide tolerances. Environmental Fate 
studies determine rates of hydrolysis, photodegradation, 
leaching, dissipation, and metabolism in soil or water. 
Product Performance data provide efficacy information; 
these are useful for labeling the product or refining the 
instructions for its use. 
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Generation of these data is both time-consuming and 
costly (Fagerstone et al. 1990, Ramey et al. 1992, Poche 
1992). Studies must be done according to standards and 
protocols that are acceptable to EPA - hence, the risks 
(e.g., failure to meet deadlines, rejection of a study, 
cancellation of registrations, fraud, etc.) involved in 
trusting these studies to a commercial laboratory can be 
great. Consider, for example, the plight of several 
registrants who, as clients of Craven Laboratories, a 
commercial testing laboratory, lost an estimated $11 
million because of the fraudulent practices of that 
laboratory (Anonymous 1993). In this case (U.S. v. 
Craven Laboratories, DC WTexas, No. A 92 CR 152, 
plea agreement reached 12/2/93), the laboratory owner, 
the quality assurance officer, and two of the laboratory's 
employees were indicted by a federal grand jury in 
September 1992 on criminal charges that they tampered 
with pesticide tests conducted for 11 major manufacturers 
and the EPA in violation of the FIFRA. The indictment 
also alleged that the defendants tried to cover up a federal 
investigation of the laboratory's practices, and, in 
addition, that the laboratory's falsification of test data 
defrauded pesticide manufacturers of money they had paid 
for the tests and caused false information to be submitted 
to the EPA. Care and diligence in the contract research 
process is imperative. 
CONTRACTSANDTHECONTRACTINGPROCESS 
Registrants basically have two ways to fulfill EPA 
data requirements: 1) they can use the knowledge, skills, 
and expertise of their own staff, their own equipment, and 
their own facilities to write the protocols, conduct the 
studies, prepare a final report for submission to EPA, 
archive the raw data and specimens, and assure that all 
Good Laboratory Practice (GLP) standards have been met 
throughout the process; or 2) they can hire someone else 
to do it for them. The first option may not be practical 
because the staff, facilities, equipment, and special 
expertise needed are not available; this will likely be the 
case for some of the required studies because of their 
specialized nature. Hence, option 2-hiring a commercial 
or •contract• testing laboratory--is mandated. 
The contracting process is, essentially, an 
incorporation of the elements of a contract. Briefly, a 
contract is an agreement enforceable by law. Certain 
elements must be present in order for a contract to exist-
these are: 
• Offer - a proposal of the terms of the transaction to 
another party. 
• Acceptance - the party receiving the proposal must 
agree to the terms and conditions offered. 
• • Consideration - both parties must give up something 
of value to the other party. 
In order for the contract to be valid (enforceable), the 
following additional elements must also be present: 
• Capacity of the parties - for an agreement to be a 
contract, both parties must be legally competent to 
enter into a contract. 
• Legality of the subject matter - a valid contract 
must be for a lawful purpose; an agreement to do 
something prohibited or not authorized by law will 
not be enforced. 
• In writing if required by Jaw. 
Figure 1 illustrates the contracting process and the 
formation of a contract in the context of pesticide 
registration research based on the following scenario: the 
registrant or sponsor (one of the competent parties) has a 
need to generate data to meet a data call-in requirement 
issued by EPA (the legal purpose); after unsuccessful 
attempts to have the requirement waived by EPA, the 
registrant makes plans to hire a contract laboratory to do 
the study; the registrant or sponsor issues a solicitation to 
potential contractors asking for proposals; various testing 
laboratories send in proposals (the offers) to do the study; 
the sponsor evaluates the proposals and selects (the 
acceptance) one of the laboratories (the other competent 
party) to do the study; the contract laboratory conducts 
the study under the supervision of the sponsor; the 
registrant gets the needed report for submission to EPA 
and the laboratory gets paid (mutual consideration). It 
sounds simple-but it is complex. 
The specific sequence of events which a registrant will 
follow to hire a contract laboratory depends on several 
factors. For example, is the registrant a government 
agency, a commercial business, or a member of a data-
gathering consortium? A government agency will have to 
follow a more restrictive, time-consuming sequence than 
will a private business or a data-gathering consortium 
because of internal regulations and procedural 
requirements. Private industry or consortia can deal 
directly with any source and need not be concerned with 
competition; government agencies are required to seek full 
and open competition. This makes the selection process 
longer and more complicated, but it offers a slightly 
greater degree of protection should a dispute or breach 
arise. The time factor must be considered because the 
data requirements established by EPA generally have 
submission deadlines associated with them. 
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Figure 1. Schematic illustration of the contracting process 
within the context of a pesticide registration research scenario. 
CONTRACT LABORATORIES - SOURCES 
There are numerous commercial testing laboratories, 
both in this country and abroad. Locating a contract 
laboratory to meet specific needs is not a difficult task; 
but to do it effectively can be time-consuming and 
requires diligence. There are published directories of 
commercial testing laboratories (e.g. , ASTM 1990, 
Regulatory Assistance Corp. _ 1991, Freudenthal 1992). 
These provide diverse information on the capabilities and 
specialties of each laboratory, species used, associated 
support capabilities, equipment, staff, accreditation 
information, and key contact persons. Although the 
directories can be a valuable aid in contract laboratory 
selection, they should be used only as an initial step-sort 
of like looking through the yellow pages. Following 
identification of a number of potential candidates, 
additional information should be sought about these 
specific laboratories and their operations. Key steps 
should include the following: 
• Literature/Brochures - ask for literature; much can 
be learned about a laboratory even from a cursory 
review of the material provided (e.g. is it of 
professional quality or of a "desk-top" publisher 
quality?; does it include a listing and qualifications 
of principal staff?; does it provide a description of 
the facilities, support capabilities, etc.?) 
• Protocols - ask for generic protocols of the studies 
you are interested in; compare these with the EPA 
Pesticide Assessment Guidelines to see if they 
conform. 
• Price Estimates - ask for price estimates (if not 
included in the literature); compare these with 
estimates from other laboratories. Although prices 
will vary, estimates should be roughly comparable; 
be wary of relatively very high or very low 
estimates. 
• Schedule - ask when your study could be started. 
Since you may have a deadline to meet with EPA, 
scheduling of the study to allow sufficient time for 
completion of all phases (and some unanticipated 
delays) is important. Allow at least one month for 
review/revision of final reports. Some laboratories 
tend to sign up more clients than they can serve in 
a timely and effective manner. 
• Site Visits - ask if the laboratory permits sponsor or 
sponsor's representative site visits. If they 
discourage this or seem hesitant about it, take your 
business elsewhere. 
These steps will give you an initial idea about which 
laboratories you may be interested in and which ones 
should receive a copy of the solicitation or request for 
proposals. The amount of time and resources dedicated 
to laboratory selection will depend on the nature of the 
studies to be conducted. Selection of a qualified 
laboratory to conduct comparatively simple acute toxicity 
studies or product chemistry studies is far less critical and 
involved than the selection of a laboratory to conduct a 
complex series of environmental fate studies, a long-term 
neurotoxicity study, or a multi-generation reproduction 
study. 
CONTRACT LABORATORIES - SOLICITATIONS 
Before a contract lab can submit a study proposal to 
the registrant or sponsor, they must know what the needs 
of the sponsor are.· It is the sponsor's responsibility to 
define its requirements in the "solicitation" or "request for 
proposals" (also referred to as the terms-of-reference, 
statement-of-work, or specifications). The more detailed 
and specific this document is, the easier it is for the 
laboratory to respond and the less likely that a 
misunderstanding will occur which may not be realiud 
until later. 
The terms-of-reference or statement-of-work included 
in the solicitation tells the prospective contractor what 
work will be required, the conditions under which the 
work must be conducted (e.g. , it must be done in 
compliance with Good Laboratory Practice Standards and 
other appropriate regulations), bow the proposals will be 
iwessed (i.e., the evaluation criteria including the relative 
importance attached to each criterion), and what the 
obligations will be. It enables the contractor to assess its 
capabilities in light of the contract requirements. 
General guidelines for developing the terms-of-
reference are as follows: 
• Describe the scope of work to be done as a clearly 
defined task or tasks with a definite goal, 
objective, or target. 
• Establish meaningful parameters of measure. 
• Allow sufficient flexibility to permit proposers 
some degree of latitude in structuring a technical 
approach to solve the problem. 
• Avoid the use of abstract or vague words or words 
with multiple meanings. 
One item that will be prominent in the selection 
process is cost. However, if cost or price is not to be the 
primary selection factor (i.e. , technical merit may be 
considered more important), this must be clearly stated in 
the solicitation. 
As a basic rule, the solicitation should be explicit 
enough to give offerors reasonable notice of what factors 
are actually going to make a difference in selecting the 
contractor for the job. There are at least two reasons for 
this: first, if the offerors must guess about what you 
want, you risk inviting proposals from inadequately 
qualified sources and proposals which do not reflect what 
you need. Secondly, some offerors may correctly guess 
what you want while others may not. Those who fail to 
do so may contest the acquisition process in court. The 
EPA publishes Pesticide Assessment Guidelines that set 
forth standards and protocols for testing that are 
acceptable to the Agency. These guidelines are helpful to 
the sponsor in drafting the terms-of-reference and to the 
laboratory in designing the study protocol. 
Once the sponsor's needs are known by the contract 
laboratories, they prepare proposals. Depending on the 
laboratory and the nature of the study, these can vary 
from a relatively simple, unassuming document to multi-
volume, state-of-the-art productions that are intimidating 
by their sheer volume and mass. And each one must be 
carefully read and evaluated. 
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CONTRACT LABO RA TORIES -
EVALUATION/SELECTION 
Technical evaluation is the consideration of the 
technical merit of the proposals. It is best done by an 
evaluation panel using an evaluation plan and scoring 
system designed before release of the solicitation. An 
example of such a plan is shown in Figure 2 . In order 
for the evaluation of proposals received in response to a 
solicitation to be legally valid, the evaluation must be 
conducted in accordance with the "rules of the game;" 
these are the evaluation criteria announced in the 
solicitation. For example, if two competitors' proposals 
were judged equal in technical merit on the basis of 
criteria announced in the solicitation but the winner was 
selected because it was located in the same city as the 
sponsor (a criterion not made known to the competitors), 
the unsuccessful offeror would have a valid basis for 
protesting the selection and award of the contract to the 
other offeror. Evaluation panelists should document 
their rationale for the ratings reached on each proposal 
(Figure 3). This demands time and effort but it is 
important for several reasons. When a panelist reaches 
a conclusion, the rationale or basis for it is clear at the 
time but it may be unclear or forgotten days, or weeks, 
or several other proposals later. If individual evaluators 
cannot remember how they arrived at their ratings, it will 
be difficult to develop a written rationale for the final 
panel evaluation report; this may become a critical point 
in the event of a protest. Unsuccesful offerors are 
entitled to a "debriefing" as to why they were not 
selected. If substantiated reasons cannot be offered, the 
award· may be subject to protest on the grounds that it 
was made arbitrarily. The technical evaluation of 
proposals will yield a ranking of the offerors and may 
eliminate some from further consideration. 
Guidelines for Technical Evaluation of Proposals 
The proposals will be evaluated by a three-member panel. Each panelist will read each proposal completely and 
carefully, evaluating the proposal on the basis of the following criteria which appeared in the solicitation as the factors 
to be used to determine the most technically competent proposal: 
• The offeror's understanding of the tenns-of-reference as evident from the logic, clarity, and thoroughness of the 
proposal. 
• 'lbe approach proposed to accomplish the scientific and technical objectives. 
• The availability and competence of experienced scientific technical personnel. 
• The offeror's experience in the field. 
• The availability of the necessary research facilities and equipment. 
Scoring: 
Panelists will score each criteria by assigning a numerical value based on the following scale . 
. ... .. .. . 5 .. .. ..... 4 . .. . .. ... 3 .. ..... .. 2 .. ... .... 1 ... .... .. .. . . 
0 E A F P U 
0 = Outstanding (5.0-5.9); E = Excellent (4.0-4.9); A = Average (3.0-3.9); F = Fair (2.0-2.9); 
P = Poor (1.0-1.9); U = Unacceptable (0.0-0.9). 
Naqative: 
In addition to assigning a numerical score to each factor, evaluators will prepare a narrative statement explaining 
their reasons for scoring the criteria as they did. The narrative statements should be concise but contain sufficient detail 
to fully explain the score. 
Ambiguities: 
Evaluators may not contact any offeror to obtain clarification of language in the proposal that may be ambiguous; 
in such instances the item should be identified as a possible item for discussions but the offeror should be downgraded 
for lack of clarity. 
Inadequate Substantiation: 
Evaluators may not contact any offeror for additional information because the proposal fails to provide adequate 
substantiating information; identify the item as a possible item for discussion and downgrade the offeror for lack of 
adequate substantiation. 
Strengths and Weaknesses: 
Evaluators should identify the strengths and weaknesses of proposals. 
Deficiencies: 
Evaluators should identify each aspect in which an offeror, or what is offered, is inadequate to meet the sponsor's 
minimum requirements. For each deficiency identified the evaluator should provide: an explanation as to why it is felt 
that one or more minimum requirements will not be met; an opinion (with supporting rationale) as to whether the 
deficiency can be remedied; an opinion (with supporting rationale) as to whether remedying the deficiency would amount 
to allowing submission of a second proposal. 
Competitive Range: 
Evaluators should identify any proposal that does not have a reasonable chance of being selected and explain why 
they believe that to be the case. 
Ranking: 
The sum of the criteria scores = the proposal score. The sum of the proposal scores = the ranking score with the 
high score ranked No. 1. 
Figure 2. Sample guideline for technical evaluation of proposals; the evaluation criteria will be the same as those included in the 
solicitation. 
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Technical Evaluation of Proposals 
Company Name ____________ _ 
Panel Member 
-------------
1) The offeror's understanding of the terms-of-reference as evident from the logic, clarity, and thoroughness of the 
proposal. 
Numerical Rating: -----
Narrative Statement: 
2) The approach proposed to accomplish the scientific and technical objectives. 
Numerical Rating: -----
Narrative Statement: 
3) The availability and competence of experienced scientific and technical personnel. 
{ 
Numerical Rating: 
-----
Narrative Statement: 
4) The offeror's experience in the field. 
Numerical Rating: -----
Narrative Statement: 
S) The availability of the necessary research facilities and equipment. 
Numerical Rating: 
-----
Narrative Statement: 
General Comments/Observations: 
Figure 3. Sample technical evaluation rating form to be used by each panel member to document his or her evaluation of each 
proposal. 
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The final step in the selection process is the site visit 
or pre-award survey. This may involve visiting only one 
laboratory if the technical evaluation revealed it to be a 
clear winner, or it may involve visiting several if they 
were very closely ranked on the basis of technical merit. 
The purpose of the site visit is to meet the personnel who 
will be involved in the project, to see the facilities and 
operations firsthand, to •get a feel• for the laboratory and 
staff, to verify claims made in the proposal, and to 
finalii.e the selection. The pre-award survey should be as 
extensive as possible and focus on the offerer's 
•capability• and •capacity• as reflected by its facilities, 
equipment, staff qualifications, standard operating 
procedures, quality assurance procedures, audit history, 
accreditation, etc. It will be helpful to design a checklist 
of items to review during the site visit; a sample checklist 
is shown in Figure 4. 
Check-List of Items to Review During Site Visit 
Personnelj 
• Qualifications, experience, training for their 
assigned function. 
• Current job description and current summary of 
training. 
• Sufficient number of personnel for the timely and 
proper conduct of study. 
• Adequate safety practices and equipment. 
Study Director: 
• Scientist or other professional with appropriate 
education or training assigned. 
• Single point of study control. 
• Responsible for all aspects of the conduct of the 
study. 
Quality Assurance Unit: 
• Independent. 
• Reports to management. 
• Master schedule. 
• Inspections. 
• Good Laboratory Practices. 
• Audit history. 
Facilities: 
• Suitable sii.e, construction. 
• Separation of functions. 
• Equipment suitaable in design, capacity, and 
function - properly maintained. 
• Security. 
• Operations - SOPsfI'est substance control. 
• Animal care - food, water, bedding, pest control, 
IACUC, veterinary care. 
RCjl<>rts and Records: 
• Storage and retrieval. 
• Archives - limited access/preservation/inventory 
control/fragile materials. 
• Final reports - format/content. 
Figure 4. Sample checklist for site visits. These arc some of 
the major items that should be reviewed. An actual checklist 
can (and probably should) be much more detailed. 
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The selection of a contract laboratory is critical for 
several reasons: 
• Economics - the various toxicology, environmental 
fate, and other kinds of tests, along with 
associated services such as chemical analysis, can 
be expensive; therefore, there is a definite 
economic consideration. 
• Acceptability - the results of the study (i.e. , the 
final report) must be acceptable in both form and 
content to the EPA or other regulatory agency to 
which it will be submitted. Regardless of the 
scientific merit of the study results, if it is not 
presented in proper format, the regulatory agency 
will reject it outright. 
• Timeliness - the availability of the study results in 
time to meet the established deadline for 
submission is requisite. EPA is operating under a 
deadline imposed by Congress for registration of 
pesticides, hence they are not very sympathetic 
about delays of required submissions. 
CONTRACT ADMINISTRATION 
Once the contract laboratory has been selected and the 
contract awarded, administration of the contract is the 
responsibility of the sponsor's representative. This 
individual will have signatory responsibility for approval 
of the final study protocol and any amendments thereto as 
the study progresses. It is the representative's job to get 
the required amount of the test substance to the study 
director, and to coordinate other activities as necessary to 
facilitate initiation and completion of the study. The most 
important step of contract administration is to review the 
requirements and specific obligations set forth in the 
contract. The terms-of-reference or contract 
specifications contain the details of these requirements and 
obligations. Although the sponsor's representative may 
have written the specifications, it is imperative that the 
entire contract package be read and reviewed in order to 
properly discharge the responsibilities of contract 
administration. It is a fundamental rule of contract law 
that the obligations of the parties are established and 
governed by the language of the contract. During the 
selection and pre-award process, discussions and 
negotiations may have involved a number of revisions, 
changes, additions, or deletions; but what actually 
governs is precisely what was agreed to by both parties in 
the contract. The final written contract words are taken 
to mean exactly what they say. 
Contract administration or contract monitoring is 
intended to ensure that the sponsor obtains the following 
performance elements from the contractor: 
• Delivery of the specific item(s) called for in the 
contract. 
• Avoidance of waste of time and/or money. 
• Good quality. 
• Performance in a timely fashion. 
• Performance within the budget. 
Monitoring may be done by on-site inspection, 
progress reports, and telephone conversations. The 
sponsor has the right to inspect and check the work 
(e.g., audit of raw data) as the study progresses. The 
contractor's written progress reports can be of significant 
help in providing a picture of work progress under the 
contract. Ideally, a combination of inspections, written 
progress reports, and ongoing communications between 
the contractor's study director and the sponsor's 
representative will contribute to a successful project. 
Contract monitoring does not, however, mean taking 
charge and usurping the authority of the study director; 
the laboratory and the study director were hired because 
of their particular knowledge and skills in a specific 
scientific field. Contract monitoring means: 
• Keeping well-informed of what the contractor is 
doing. 
• Using technical expertise (if needed) to identify 
the contractor's actions or failures to act that 
clearly affect the quality of the work underway 
(and hence the quality of the end result). 
• Calling the contractor's attention to deficiencies. 
• Working out appropriate action to deal with 
deficiencies. 
Care and diligence in the contracting process will 
contribute to selection of the best contract laboratory to 
conduct the required studies and careful administration of 
the contract, once awarded, will contribute to a successful 
completion of the project and to the mutual satisfaction 
and benefit of the Jl!lrlies to the contract. 
CASE STUDIES 
The following case studies illustrate some of the kinds 
of things that can occur during the contract research 
process. These are not exhaustive, only representative of 
different problems or events that have occurred during our 
contracting experience; they are presented for their value 
as learning experiences. 
CASE #1: 
Situation - Studies of acute avian dietary toxicity 
(LC50) in quail and duck were required. An analytical 
method for measuring the levels of test substance in the 
diets presented to the test birds was needed before the 
studies could be done. Two contracts to two different 
laboratories were set up - one for the toxicity study, and 
one for the method development. It took more than three 
years before final reports on these eight-day studies were 
available for submission to EPA. 
Analysis - This case involves numerous points: 1) 
unwise division of responsibility and concomitant lack of 
control, 2) lack of definition of specific needs, 3) multiple 
changes of sponsor's representative, and 4) lack of 
continuity of responsible parties resulting in general 
confusion and delay. 
Point - Assign a single pennanent sponsor's 
representative to coordinate all aspects of a contract study. 
Avoid separate contracts for sub-portions of the work. If 
technical advise is needed, assign a technical advisor to 
assist the representative. 
CASE #2: 
Situation - This involved a primary eye 1mtation 
study in rabbits. Severe irritation was noted by day 3 
of a planned 14-day test. The study director 
recommended stopping the study for reasons of 
humaneness. The sponsor's representative, acting on the 
belief that EPA would reject the study if observations 
were not continued for 14 days, instructed the study 
director to continue the test (EPA had been asked for 
permission to terminate but had not responded). The test 
was continued until day 8 when a veterinary 
ophthalmologist was consulted. Based on his 
recommendation, the test was terminated and EPA later 
concurred with this decision. 
Analysis - The EPA Guideline for this test does not 
specify a duration for the observation period and in fact 
states that it • ... should not be fixed rigidly but should be 
sufficient to of the effects observed. • Among the 
regulations applicable to toxicology studies in addition to 
FIFRA, and 40 C.F.R. parts ISO to 189, are the Animal 
Welfare Act (AW A), as amended, and associated 
regulations in 9 C.F.R. parts l , 2, and 3. A basic aim of 
the AW A is to minimii.e pain and distress. In this case, 
the animals underwent the effects of the test substance for 
five more days after the study director recommended 
termination. Several factors contributed to this situation; 
the laboratory did not have a staff veterinarian, and, 
although EPA was contacted, the EPA respondent may or 
may not have been knowledgeable of the AW A 
requirements. Termination or continuation was a 
judgement call on the part of the sponsor's representative 
who was concerned with the integrity of the study and 
EPA' s reaction to termination. 
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Point - Be thoroughly familiar with all applicable 
regulations and act accordingly. 
CASE#3: 
Situation - This case involved a single environmental 
fate study, accumulation in fish. The contract 
laboratory' s study director subcontracted the biology 
portion (i.e., exposure of fish to the test substance in both 
range-finding and definitive studies) to another laboratory. 
The draft final report received from the contract 
laboratory basically consisted of a one-paragraph 
explanation that the study had been done in three phases 
as described in three separate study reports (i.e., an acute 
toxicity study [the range-finding], a bioconcentration and 
elimination of residues study [the definitive exposure], 
and a report on the metabolite identification in fish 
tissues. The separate reports were, in fact, three separate 
studies, each with its own study director. 
Analysis - This was a violation of Good Laboratory 
Practice standards and the EPA format guidelines for 
submission of data. It would have been rejected outright 
by EPA. Apparently, the study director did not make 
clear that the studies to be done by the subcontractor were 
sub-parts or phases of a larger study for which he was the 
study director; multiple study directors is a violation of 40 
C.F.R. §160.33. 
Point - Don't assume that the contractor's study 
director or even the Quality Assurance representative are 
familiar with the requirements and procedures for sub-
contracting parts of studies which will be submitted to a 
regulatory agency. Discuss these matters in detail with 
the contract before the study begins. 
CASE#4: 
Sjtuation - A contnct was awarded to a laboratory for 
an acute toxicity study. Tentative arrangements for a site 
visit were reluctantly agreed to by the laboratory's 
director. Following persistent phone calls from the 
sponsor's representative in an effort to finali:ze 
arrangements, the visit was refused by the contractor one 
day before it was to take place. Various reasons were 
1iven, subsequent calls were not returned, finally the 
phone was disconnected. 
Analysis -The contnct was awarded without adequate 
investigation of the laboratory, its history, staff 
qualifications, etc. It was later learned that the laboratory 
had gone out of business. 
Point - Check out the laboratory's reputation. 
Contracts should not be awarded solely on the basis of 
written information or verbal assurances from laboratory 
staff nor on the basis of cost alone. Site visits should be 
arranged before contract award and any reluctance to 
allow a visit should be considered reason not to award. 
ACKNOWLEDGMENTS 
We thank the following laboratories who graciously 
provided photographs used in the oral presentation of this 
paper: Bio-Life Associates, Ud.; Hazleton Wisconsin, 
Inc.; International Research and Development 
Corporation; Springboro Laboratories, Inc. , Life Sciences 
Division; Springboro Laboratories, Inc. , Environmental 
Sciences Division; and SRI International. We thank our 
colleagues, C. A. Ramey, K. A. Fagerstone, and E.W. 
Schafer, Jr. for critical review of the DWluscript, and C. 
A. Schafer for preparation of slides. 
LITERATURE CITED 
ANIMAL WELFARE ACT (AWA), 7 U.S.C. §§ 2131-
2157, as amended. 
ANIMAL WELFARE REGULATIONS, 9 U.S.C. parts 
1, 2, and 3. 
167 
ANONYMOUS. 1993. False Craven data cost 
registrants $11 million, Justice says. Pesticide & 
· Toxic Chemical News, 22(8):8. 
ASTM. 1990. Directory of testing laboratories: 1991 
edition. American Society for Testing and Materials. 
Philadelphia, PA. 360 pp. 
CONNER, J. D. , L. S. EBNER, S. W. LANDFAIR, 
C. A. O'CONNOR, K. E. WEINSTEIN, and A. P. 
JOVANOVICH. 1991. Pesticide Regulation 
Handbook. Executive Enterprises Puhl. Co., Inc., 
New York, NY. 540 pp. 
FAGERSTONE, K. A. , R . W. BULLARD, and C. A. 
RAMEY. 1990. Politics and economics of 
maintaining pesticide registrations. Proc. Vertebr. 
Pest Conf. 14: 8-11. 
FEDERAL INSECTICIDE, FUNGICIDE, AND 
RODENTICIDE ACT (FIFRA), 7 U.S.C. §§ 136-
136y (1988), as amended by the Food, Agriculture, 
Conservation, and Trade Act of 1990, Pub. L. 
No.101-624, 104 Stat. 3359 (Nov. 28, 1990). 
FREUDENTHAL, R. I., editor. 1992. Directory of 
toxicology Laboratories offering contract services. 
Hill and Garnett Publishing, Inc., Boca Raton, FL. 
303 pp. 
GILES, K. H. , chief editor. 1991. Code of Federal 
Regulations, Title 40-Protection of Environment, 
parts 150 to 189. Office of the Federal Register, 
National Archives and Records Administration, 
Washington. 673 pp. 
POCHE, R. M., 1992. How OLP provisions influence 
costs of rodenticide field evaluations. Proc. Vertebr. 
Pest Conf. 15: 245-248. 
RAMEY, C. A., E. W. SCHAFER, JR., K. A. 
FAGERSTONE, and S. D. PALMATEER. 1992. 
Back to the future for APHIS's vertebrate pesticides. 
Proc. Vertebr. Pest Conf. IS: 17-21. 
REGULATORY ASSISTANCE CORPORATION. 
1991. Directory of toxicological and related testing 
laboratories. Hemisphere Publishing Corporation, 
New York, NY. 103 pp. 
